헬스케어 및 생명과학 분야 여정 관리 예측(2026-2032년)

The Journey Management in Healthcare & Life Sciences Market is projected to grow by USD 43.88 billion at a CAGR of 23.59% by 2032.

Journey management in healthcare and life sciences is becoming a strategic capability for improving patient experience, clinical coordination, therapy adherence, trial participation, and stakeholder engagement across increasingly complex care ecosystems. As patients move between digital front doors, primary care, specialty care, diagnostics, pharmacies, payers, clinical trials, home care, and post-treatment support, organizations are under pressure to deliver connected, personalized, compliant, and measurable journeys. The sector's focus is shifting from isolated touchpoints to longitudinal healthcare journey orchestration that integrates patient data, omnichannel communication, care navigation, consent management, and outcomes monitoring. This transformation is supported by the broad adoption of electronic health records, telehealth, remote patient monitoring, digital therapeutics, patient engagement platforms, real-world evidence programs, and interoperability frameworks such as HL7 FHIR. For life sciences organizations, journey management is also essential for understanding healthcare professional engagement, patient support programs, treatment access barriers, pharmacovigilance workflows, and evidence generation across the product lifecycle. In this environment, successful healthcare journey management depends on trusted data governance, privacy-by-design architecture, inclusive design, clinical workflow alignment, and the ability to convert patient and provider insights into timely interventions that improve access, experience, adherence, and care continuity.

Transformative Shifts Reshaping Healthcare Journey Management

The healthcare and life sciences landscape is undergoing transformative shifts driven by consumerization of care, regulatory modernization, value-based care models, and the expansion of digital health infrastructure. Patients increasingly expect healthcare experiences that resemble high-quality digital services in other sectors, including seamless appointment scheduling, transparent communication, personalized education, remote access, and proactive support. At the same time, providers are facing workforce constraints, administrative burden, fragmented data, and rising demand for coordinated care across chronic disease management, behavioral health, oncology, rare diseases, and post-acute services. These pressures are accelerating investment in journey analytics, care pathway mapping, patient engagement automation, and omnichannel communication strategies. Regulatory and standards-based initiatives are also reshaping implementation conditions, with interoperability mandates, data protection rules, digital health assessment frameworks, and health information exchange programs encouraging more structured and secure data flows. In life sciences, the shift from product-centric commercialization to patient- and outcome-centric engagement is expanding the role of journey management in treatment initiation, access support, adherence programs, decentralized and hybrid clinical trials, medical affairs engagement, and patient-reported outcomes. The result is a more connected ecosystem where journey management is no longer a customer experience function alone, but a cross-functional operating model linking clinical quality, compliance, commercial effectiveness, and health outcomes.

Cumulative Impact of Artificial Intelligence on Journey Management

Artificial intelligence is having a cumulative impact on journey management by enabling more precise segmentation, predictive engagement, operational automation, and personalized healthcare communication. AI-supported analytics can identify patterns in missed appointments, medication nonadherence, care gaps, call center interactions, patient-reported outcomes, and claims or clinical data to support earlier intervention. Natural language processing can help extract insights from unstructured clinical notes, patient messages, contact center transcripts, and adverse event reports, while conversational AI can support triage, education, scheduling, benefits navigation, and routine service inquiries when implemented with appropriate clinical governance. In life sciences, AI is enhancing site selection, trial matching, patient recruitment, medical information workflows, safety signal detection, and omnichannel engagement planning. However, the impact of AI is inseparable from risks around data quality, bias, explainability, cybersecurity, consent, and regulatory compliance. Healthcare organizations must ensure that AI-enabled journey management does not worsen inequities by underrepresenting vulnerable populations or by relying on incomplete data. Responsible adoption requires human oversight, auditability, model validation, secure data infrastructure, and alignment with clinical, legal, and ethical standards, including emerging AI governance frameworks. When these controls are in place, AI can help organizations move from reactive service delivery to predictive, personalized, and outcome-oriented journey orchestration.

Key Regional Insights Across Healthcare Journey Management

In Asia-Pacific, journey management is being shaped by rapid digital health adoption, expanding telemedicine access, mobile-first patient engagement, and government-led health system modernization across major economies. Countries with large populations and diverse care access challenges are using digital platforms to improve appointment access, chronic disease management, remote consultations, and public health outreach, while mature markets in the region are advancing interoperable records, aging-care technologies, and precision medicine programs. North America remains a highly developed environment for healthcare journey management due to widespread electronic health record adoption, strong payer-provider data ecosystems, advanced patient engagement platforms, and growing emphasis on value-based care, care navigation, and digital front-door strategies. In Latin America, adoption is supported by expanding private healthcare networks, telehealth normalization, and growing interest in digital access tools, although infrastructure disparities, affordability constraints, and fragmented reimbursement systems influence implementation maturity. Europe is characterized by strong privacy regulation, national digital health strategies, cross-border health data initiatives, and a policy focus on patient rights, interoperability, and equitable access, making governance and trust central to journey management deployment. The Middle East is advancing journey management through national health transformation programs, smart hospital initiatives, digital identity infrastructure, and investment in preventive care and medical tourism. Across Africa, journey management is developing around mobile health, community-based care, donor-supported digital health programs, and efforts to strengthen primary care access, with progress depending on connectivity, workforce capacity, health data governance, and sustainable financing.

Key Group Insights Across Strategic Healthcare Economies

Within ASEAN, journey management is influenced by mobile-first healthcare engagement, rising demand for affordable care access, cross-border medical travel, and public-private digital health initiatives that support teleconsultation, e-pharmacy, and chronic disease follow-up. The GCC is advancing rapidly through national digital health strategies, integrated hospital networks, health information exchange, and ambitious transformation agendas that emphasize preventive care, patient experience, and data-driven service delivery. The European Union provides one of the most policy-driven environments for journey management, with strong emphasis on privacy, interoperability, digital identity, electronic health records, and secure secondary use of health data for research and innovation. BRICS countries present a diverse but highly significant context, combining large patient populations, expanding digital public infrastructure, local health technology innovation, and strong demand for scalable journey solutions that address access, affordability, chronic disease burden, and fragmented care pathways. The G7 reflects mature adoption of digital health, advanced life sciences ecosystems, strong regulatory oversight, and increasing focus on health system resilience, aging populations, and personalized care. NATO member countries, many of which overlap with advanced healthcare economies, are emphasizing cybersecurity, resilient health infrastructure, secure data exchange, and continuity of care, making trust, interoperability, and operational preparedness important themes in journey management strategy.

Key Country Insights for Healthcare Journey Management

The United States is a leading adopter of journey management capabilities due to mature digital health infrastructure, strong investment in patient engagement, value-based care initiatives, interoperability rules, and extensive use of clinical, claims, and consumer data for care coordination and access management. Canada's approach is shaped by provincial health systems, digital health modernization, virtual care expansion, and a policy focus on equitable access and privacy. Mexico is advancing through telehealth, private-sector digital services, and efforts to improve access across urban and rural populations, while Brazil is using digital health tools to support large-scale public and private healthcare delivery, chronic disease management, and patient communication. The United Kingdom is focused on digital front doors, electronic records, waiting list management, and integrated care systems, making patient flow and coordinated care central to journey management. Germany is strengthening digital health through electronic patient records, digital health applications, and interoperability initiatives, while France is emphasizing secure health data infrastructure, digital identity, telemedicine, and coordinated care pathways. Russia's healthcare journey management environment is influenced by public-sector digitalization, telemedicine development, and regional differences in healthcare access. Italy and Spain are advancing digital health through regional healthcare systems, electronic records, teleconsultation, and chronic disease programs, with implementation shaped by decentralized governance. China is scaling digital health through internet hospitals, mobile engagement, artificial intelligence applications, and large-scale hospital digitalization. India is experiencing strong momentum through digital public health infrastructure, telemedicine, digital identity-linked services, and mobile-first patient access models. Japan's journey management priorities are tied to aging population needs, remote monitoring, care coordination, and health data utilization, while Australia emphasizes telehealth, national digital health records, rural access, and patient-centered care. South Korea is distinguished by advanced connectivity, strong hospital digitalization, health technology adoption, and growing interest in data-driven personalized care.

Actionable Recommendations for Healthcare and Life Sciences Leaders

Industry leaders should treat journey management as an enterprise-wide capability rather than a standalone digital engagement project. Organizations should begin by mapping high-impact journeys such as access to care, diagnosis, treatment initiation, medication adherence, clinical trial participation, discharge planning, chronic disease follow-up, and patient support enrollment. Leaders should strengthen interoperability between electronic health records, customer relationship management systems, contact centers, patient portals, consent platforms, and analytics environments to create a unified view of the patient and provider journey. Privacy, cybersecurity, and consent management must be embedded from the design stage, especially when using sensitive health data and AI-enabled decision support. Healthcare and life sciences teams should prioritize inclusive design by accounting for language, disability, health literacy, rural access, cultural context, and digital divide factors. AI initiatives should be governed through transparent model validation, bias monitoring, human review, and documented accountability. Organizations should also align journey metrics with clinical and operational outcomes, including access, adherence, care gap closure, patient-reported experience, time to therapy, trial retention, and service resolution. Cross-functional governance involving clinical, compliance, technology, operations, commercial, and patient advocacy stakeholders is essential to scale journey management responsibly and sustainably.

Research Methodology for Journey Management Analysis

The research methodology for evaluating journey management in healthcare and life sciences should combine secondary research, expert validation, and structured market intelligence practices without relying on speculative sizing or forecasting. Secondary research should include peer-reviewed clinical literature, public health authority publications, regulatory guidance, interoperability standards, digital health policy documents, healthcare quality frameworks, clinical trial modernization resources, and publicly available technology adoption evidence. Primary validation should involve interviews or structured discussions with healthcare executives, clinicians, care coordinators, digital health leaders, life sciences commercial and medical affairs professionals, patient support specialists, compliance experts, and health technology stakeholders. The analysis should assess technology adoption drivers, implementation barriers, regulatory conditions, workflow integration, data governance maturity, patient engagement models, AI readiness, and regional healthcare infrastructure. Triangulation across policy evidence, operational practice, and expert perspectives helps ensure that insights are data-backed, current, and relevant. The methodology should also include thematic analysis of regional and country-level digital health strategies, privacy regulations, health information exchange programs, telehealth adoption patterns, healthcare delivery transformation initiatives, and ethical considerations for AI-enabled patient engagement.

Conclusion: Building Connected, Trusted, and Outcome-Driven Journeys

Journey management in healthcare and life sciences is becoming essential for organizations seeking to improve patient experience, care continuity, therapy adherence, clinical trial engagement, and outcome-oriented service delivery. The most effective strategies are those that connect digital touchpoints, clinical workflows, patient support services, data governance, and analytics into a coordinated operating model. Artificial intelligence, interoperability, telehealth, remote monitoring, and omnichannel engagement are expanding what is possible, but responsible execution requires privacy protection, bias mitigation, clinical oversight, and trust-centered design. Regional differences in policy, infrastructure, reimbursement, digital maturity, and population needs will continue to shape adoption patterns across Asia-Pacific, North America, Latin America, Europe, the Middle East, and Africa. Industry leaders that invest in secure data foundations, inclusive engagement models, measurable outcomes, and cross-functional governance will be better positioned to deliver more personalized, efficient, and equitable healthcare journeys.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Journey Management in Healthcare & Life Sciences Market, by Channel

• 7.1. Introduction
• 7.2. Digital
  • 7.2.1. Mobile Apps
  • 7.2.2. Web Portals
• 7.3. In Person
  • 7.3.1. Front Desk
  • 7.3.2. Onsite Kiosks
• 7.4. Telehealth
  • 7.4.1. Remote Monitoring
  • 7.4.2. Video Consultation

8. Journey Management in Healthcare & Life Sciences Market, by Deployment

• 8.1. Introduction
• 8.2. Cloud
• 8.3. On Premises

9. Journey Management in Healthcare & Life Sciences Market, by Component

• 9.1. Introduction
• 9.2. Software
  • 9.2.1. Patient Journey Management Platforms
  • 9.2.2. Care Pathway Orchestration Software
  • 9.2.3. Omnichannel Engagement Platforms
  • 9.2.4. Journey Analytics & Mapping Tools
• 9.3. Services
  • 9.3.1. Implementation & Integration Services
  • 9.3.2. Consulting & Advisory Services
  • 9.3.3. Managed Journey Operations Services

10. Journey Management in Healthcare & Life Sciences Market, by End User

• 10.1. Introduction
• 10.2. Clinics
  • 10.2.1. Private Clinics
  • 10.2.2. Public Clinics
• 10.3. Hospitals
  • 10.3.1. General Hospitals
  • 10.3.2. Specialty Hospitals
• 10.4. Pharmacies
  • 10.4.1. Hospital Pharmacies
  • 10.4.2. Retail Pharmacies
• 10.5. Research Institutes
  • 10.5.1. Academic
  • 10.5.2. Private Foundations

11. Journey Management in Healthcare & Life Sciences Market, by Application

• 11.1. Introduction
• 11.2. Appointment Scheduling
  • 11.2.1. Automated Reminders
  • 11.2.2. Online Booking
• 11.3. Compliance Management
  • 11.3.1. Audit Trail
  • 11.3.2. Policy Management
• 11.4. Data Analytics
  • 11.4.1. Operational Analytics
  • 11.4.2. Predictive Analytics
• 11.5. Patient Engagement
  • 11.5.1. Feedback Systems
  • 11.5.2. Surveys

12. Journey Management in Healthcare & Life Sciences Market, by Region

• 12.1. Asia-Pacific
• 12.2. North America
• 12.3. Latin America
• 12.4. Europe
• 12.5. Middle East
• 12.6. Africa

13. Journey Management in Healthcare & Life Sciences Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Journey Management in Healthcare & Life Sciences Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2025
• 15.2. FPNV Positioning Matrix, 2025
• 15.3. Market Concentration Analysis, 2025
  • 15.3.1. Concentration Ratio (CR)
  • 15.3.2. Herfindahl Hirschman Index (HHI)
• 15.4. Recent Developments & Impact Analysis, 2025
• 15.5. Product Portfolio Analysis, 2025
• 15.6. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Adobe Inc.
• 16.2. Aktana, Inc.
• 16.3. American Well Corporation.
• 16.4. Cedar Cares, Inc.
• 16.5. Cegedim SA.
• 16.6. Cencora, Inc.
• 16.7. CipherHealth Inc.
• 16.8. DarioHealth Corp.
• 16.9. GetWellNetwork, Inc.
• 16.10. Health Catalyst, Inc.
• 16.11. Hyro AI Inc.
• 16.12. Indegene Limited.
• 16.13. IQVIA Holdings Inc.
• 16.14. Luma Health, Inc.
• 16.15. Medallia, Inc.
• 16.16. Memora Health Inc.
• 16.17. Microsoft Corporation.
• 16.18. mPulse, Inc.
• 16.19. National Research Corporation.
• 16.20. NICE Ltd.
• 16.21. OptimizeRx Corporation.
• 16.22. Oracle Corporation.
• 16.23. Pegasystems Inc.
• 16.24. Phreesia, Inc.
• 16.25. Qualtrics International Inc.
• 16.26. Relatient, Inc.
• 16.27. Salesforce, Inc.
• 16.28. Seamless Mobile Health Inc.
• 16.29. SonarMD, Inc.
• 16.30. Teladoc Health, Inc.
• 16.31. Twilio Inc.
• 16.32. Upfront Healthcare Services, Inc.
• 16.33. Veeva Systems Inc.
• 16.34. Verint Systems Inc.